ZACHARY R BARKER
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- FULTON, MO
- NPI
- 1760041875
- Received
- $1,402 in 77 records, 2022 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 13 | $265 |
| 2024 | General payment | 41 | $730 |
| 2023 | General payment | 16 | $293 |
| 2022 | General payment | 7 | $113 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novo Nordisk Inc | 13 | $260 | 2022–2025 |
| Lilly USA, LLC | 15 | $257 | 2022–2024 |
| ABBVIE INC. | 9 | $193 | 2022–2025 |
| Amgen Inc. | 10 | $184 | 2024–2025 |
| Dexcom, Inc. | 5 | $87 | 2022–2025 |
| IDORSIA PHARMACEUTICALS US INC | 4 | $54 | 2023–2024 |
| PFIZER INC. | 3 | $51 | 2023–2024 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 | 2023–2024 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 | 2024 |
| Novartis Pharmaceuticals Corporation | 2 | $30 | 2024 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 | 2022–2024 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 | 2024 |
| Lundbeck LLC | 1 | $23 | 2024 |
| Radius Health, Inc. | 1 | $21 | 2024 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 | 2022 |
| Daiichi Sankyo Inc. | 1 | $18 | 2023 |
| Axsome Therapeutics, Inc. | 1 | $16 | 2024 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 | 2025 |
| Merck Sharp & Dohme LLC | 1 | $16 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 77 | $1,402 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-08 | Dexcom, Inc. | $16 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-11-25 | Amgen Inc. | $20 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-20 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-20 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-12 | Dexcom, Inc. | $21 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-06-23 | Dexcom, Inc. | $15 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-06-17 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-06-17 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-04 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-05-28 | Dexcom, Inc. | $19 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-02-26 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-11 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2024-12-03 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-11-18 | Phathom Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-11-05 | Axsome Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-11-04 | Paratek Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-10-28 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-10-22 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-21 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-10-14 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-10-07 | Phathom Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-03 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-30 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-09-25 | Radius Health, Inc. | $21 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-24 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-17 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-09-16 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-08-29 | Novo Nordisk Inc | $24 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-21 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-08-19 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-08-13 | Merck Sharp & Dohme LLC | $16 | Food and Beverage | In-kind items and services | GARDASIL Biological, VACCINE | 2024 | |
| 2024-07-29 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-07-24 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-07-22 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-10 | Paratek Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-07-08 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2024 | |
| 2024-06-18 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-06-11 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-05-07 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-04-29 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-02 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-01 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-03-26 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-03-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage (2 payments) | In-kind items and services | SYNJARDY Drug, DIABETES | 2024 | |
| 2024-03-13 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-03-11 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-02-28 | IDORSIA PHARMACEUTICALS US INC | $13 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, Insomnia | 2024 | |
| 2024-02-27 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-02-26 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-02-07 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-07 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-01-22 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-01-08 | IDORSIA PHARMACEUTICALS US INC | $13 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, Insomnia | 2024 | |
| 2023-11-28 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-11-15 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-11-13 | IDORSIA PHARMACEUTICALS US INC | $13 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-10-23 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-10-18 | Paratek Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2023 | |
| 2023-10-03 | Daiichi Sankyo Inc. | $18 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2023 | |
| 2023-10-02 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-09-29 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-09-11 | IDORSIA PHARMACEUTICALS US INC | $14 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-09-05 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-08-23 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-07-17 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-07-12 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-06-12 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-05-08 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-04-05 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2022-10-25 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | EMGALITY Drug, Neuroscience | 2022 | |
| 2022-10-20 | Xeris Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | GVOKE PFS Drug, Diabetes | 2022 | |
| 2022-10-18 | Dexcom, Inc. | $15 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2022 | |
| 2022-10-05 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-09-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | TRADJENTA Drug, DIABETES | 2022 | |
| 2022-08-29 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | EMGALITY Drug, Neuroscience | 2022 | |
| 2022-08-10 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Fulton, MO, county Callaway County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Fulton, MO | County Callaway County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 12,617 | 44,741 | 6,191,814 |
| Population, 2020 census P1 | 12,600 | 44,283 | 6,154,913 |
| Median age B01002 | 34.9 | 39.4 | 39.0 |
| Under 18 B01001 | 18.2% | 20.7% | 22.3% |
| 65 and over B01001 | 15.0% | 17.9% | 17.9% |
| Households B11001 | 3,978 | 16,485 | 2,508,227 |
| Foreign born B05002 | 1.6% | 0.9% | 4.5% |
| Median household income B19013 | $51,429 | $74,176 | $70,702 |
| Median family income B19113 | $74,615 | $89,499 | $91,360 |
| Per capita income B19301 | $25,045 | $33,886 | $39,695 |
| Poverty rate B17001 | 13.9% | 11.6% | 12.6% |
| Unemployment rate B23025 | 9.5% | 5.1% | 4.0% |
| Civilian labor force B23025 | 4,941 | 21,461 | 3,120,639 |
| Mean commute (minutes) B08013 | 18.4 | 24.0 | 23.5 |
| Bachelor's degree or higher B15003 | 21.7% | 24.6% | 32.4% |
| Housing units B25001 | 4,450 | 18,645 | 2,825,287 |
| Owner-occupied B25003 | 48.2% | 75.5% | 68.1% |
| Renters B25003 | 51.8% | 24.5% | 31.9% |
| Median home value B25077 | $155,900 | $201,600 | $230,300 |
| Median gross rent B25064 | $836 | $887 | $1,033 |
| White, not Hispanic B03002 | 83.9% | 88.0% | 76.3% |
| Black B03002 | 8.2% | 3.7% | 10.9% |
| Hispanic or Latino B03002 | 1.9% | 2.5% | 5.2% |
| Asian B03002 | 0.3% | 0.1% | 2.1% |
| American Indian and Alaska Native B03002 | 0.5% | 0.4% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Fulton, MO.
Comments